Law Offices of Brian Turner LLC

Archive for January, 2011|Monthly archive page

Lawsuit Loan Litigation Update

In Legal News on January 25, 2011 at 11:28 am

I have previously blogged about a class action case here in Alabama against Oasis Legal Financing and their questionable-at-best lending practices.  Litigation against Oasis, and other “non-recourse” lenders has spread, and a number of states are now looking more closely at these predatory lenders. 

On January 17, 2011, the New York Times ran a front page article titled, “Lawsuit Loans Add New Risk for the Injured.”  The article, written by Binyamin Applebaum, profiled several cases where personal injury victims took out loans from Oasis and similar lenders, only to discover after the fact that the small “non-recourse” loans ate up most of their lawsuit settlements.  While the Alabama case was not discussed in this article, lawsuits from other states challenging these unscrupulous lending practices were discussed.  The lenders, in turn, have filed lawsuits seeking to prevent states from applying lending regulations to them because, in their estimation, they aren’t making a loan but instead are buying an interest in the underlying lawsuit.  Thus, under their argument, they do not fall within truth in lending requirements or interest rate caps.  The article also demonstrated the lobbying efforts being made by Oasis and its brethren to have exceptions carved out in various states so they can continue to take advantage of injured people while dodging regulatory or judicial scrutiny. 

In an interesting letter to the editor following this story, Darren McKinney, the Director of Communications for the American Tort Reform Association, stood up against Oasis and the “non-recourse” lenders.  His letter ran in the New York Times on January 22.  Mr. McKinney pointed out the historical ban on third parties investing in lawsuits, and chided legislators who were supporting these lenders.  As Mr. McKinney pointed out, not only are the injured people taken advantage of, but the practice of lawsuit lending could be seen as encouraging the filing of more lawsuits – something the American Tort Reform Association certainly opposes. 

With such a diverse group of interests opposing Oasis and its ilk, hopefully legislatures around the country will stand up and hold these lenders to the standards that apply to all other lenders.  I applaud those who are challenging the “non-recourse” lawsuit lending industry and hope the courts and legislatures will do the right thing and reign in this predatory practice.

Chantix Litigation to be Centered in Birmingham

In Legal News on January 5, 2011 at 2:25 pm

The Birmingham News has reported that the lawsuits involving Pfizer’s anti-smoking drug, Chantix, will be consolidated before U.S. District Judge Inge Johnson in Birmingham.  The drug has been linked to psychological problems in users, including causing thoughts of suicide and in some cases the committing of suicide. 

Ernest Cory, of the law firm of Cory, Watson, Crowder & DeGaris, P.C., is leading the litigation for the plaintiffs.  Over 1,200 cases have been filed against Pfizer, and Mr. Cory suggests that at least another 1,000 are likely to be filed.  Of those cases, Mr. Cory reports that 60% involve some degree of self-harm by the patient using the drug.  Pfizer, which is represented in the litigation by Tripp Haston of the Birmingham office of Bradley Arant Boult Cummings, LLP, has denied that the drug is the cause of the psychological conditions at issue in the case.  In 2008, the FDA required Pfizer to add a “black box” warning to Chantix, alerting patients of possible serious side effects from taking the drug.   

The Multidistrict Litigation (MDL) process allows for the consolidation of cases from across the United States for pre-trial purposes.  Often the Court that runs the MDL will try a handful of representative cases.  Mr. Cory suggests trials could start some time in 2012.  Mr. Haston suggests that it is premature to point towards any trial dates as the litigation is at its very earliest stages.  Depositions of Pfizer personnel are due to begin early this year. 

If you or someone you know has been injured by a defective drug and are seeking more information, please go to our “about us” page and contact The Law Offices of Brian Turner, LLC.

Follow

Get every new post delivered to your Inbox.